(RHK) RHÖN-KLINIKUM - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0007042301

RHK: Hospital, Healthcare, Medical, Rehabilitation, Acute Care Services

RHÖN-KLINIKUM Aktiengesellschaft is a prominent healthcare provider in Germany, delivering a comprehensive range of services through its subsidiaries, including in-patient, semi-patient, and outpatient care. The company's network encompasses acute hospitals, medical care centers, and rehabilitation hospitals, catering to diverse patient needs. With a history dating back to 1973, RHÖN-KLINIKUM Aktiengesellschaft has established itself as a key player in the German healthcare landscape, leveraging its expertise to provide high-quality medical services.

As a major healthcare provider, RHÖN-KLINIKUM Aktiengesellschaft operates a significant number of facilities across Germany, offering specialized treatments and therapies. The company's acute hospitals are equipped to handle emergency cases and complex medical conditions, while its medical care centers focus on preventive care, diagnostics, and treatment of various ailments. Additionally, RHÖN-KLINIKUM Aktiengesellschaft's rehabilitation hospitals provide specialized care and therapy to patients recovering from illnesses, injuries, or surgeries, helping them regain their physical and mental strength.

Headquartered in Bad Neustadt an der Saale, Germany, RHÖN-KLINIKUM Aktiengesellschaft is a publicly traded company, listed on the XETRA stock exchange under the ticker symbol RHK. The company's common stock is traded under the ISIN code DE0007042301, and it is classified under the GICS Sub Industry category of Health Care Facilities. For more information about RHÖN-KLINIKUM Aktiengesellschaft, investors and stakeholders can visit the company's website at https://www.rhoen-klinikum-ag.com, which provides detailed insights into its business operations, financial performance, and strategic initiatives.

Additional Sources for RHK Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

RHK Stock Overview

Market Cap in USD 957m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

RHK Stock Ratings

Growth 5y -21.8%
Fundamental 32.4%
Dividend 8.87%
Rel. Strength Industry 1325
Analysts -
Fair Price Momentum 15.53 EUR
Fair Price DCF 12.60 EUR

RHK Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 71.2%

RHK Growth Ratios

Growth Correlation 3m 83.7%
Growth Correlation 12m 72.5%
Growth Correlation 5y -89.1%
CAGR 5y -1.66%
CAGR/Mean DD 5y -0.08
Sharpe Ratio 12m 1.16
Alpha 43.06
Beta 0.05
Volatility 44.66%
Current Volume 0k
Average Volume 20d 2.4k
What is the price of RHK stocks?
As of January 22, 2025, the stock is trading at EUR 14.70 with a total of 0 shares traded.
Over the past week, the price has changed by -0.68%, over one month by +5.76%, over three months by +16.67% and over the past year by +47.74%.
Is RHÖN-KLINIKUM a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, RHÖN-KLINIKUM is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.40 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RHK as of January 2025 is 15.53. This means that RHK is currently overvalued and has a potential downside of 5.65%.
Is RHK a buy, sell or hold?
RHÖN-KLINIKUM has no consensus analysts rating.
What are the forecast for RHK stock price target?
According to ValueRays Forecast Model, RHK RHÖN-KLINIKUM will be worth about 16.8 in January 2026. The stock is currently trading at 14.70. This means that the stock has a potential upside of +14.08%.
Issuer Forecast Upside
Wallstreet Target Price 14 -4.8%
Analysts Target Price - -
ValueRay Target Price 16.8 14.1%